Board of Directors

Dr. Amit Kumar, Ph.D
Dr. Amit Kumar, Ph.D Chairman, President & Chief Executive Officer

Dr. Kumar, the inventor of our Cchek™ technology, has been an investor, founder, director and CEO of several technology enterprises, both public and private. As CEO, he took CombiMatrix Corporation public and ran it for a decade while listed on the NASDAQ Global Market. He has worked in venture capital ...

Read More

Lew Titterton
Lew Titterton Lead Independent Director

Mr. Titterton previously served as a Director from August 2010 through August 2016, the last four years of which as Chairman of the Board. He also served as a Director from July 1999 to January 2003. Mr. Titterton's background is in high technology with an emphasis on health care. He ...

Read More

Dr. John Monahan, Ph.D
Dr. John Monahan, Ph.D Director

Dr. Monahan is an experienced CEO-level executive and has served on a number of biotechnology company boards over the years. He is currently a Scientific Advisory Consultant for Synthetic Biologics, Inc. (NYSE MKT: SYN) and from 2010 through 2015 he was the Sr. Executive Vice President of Research & Development ...

Read More

Dr. Arnold Baskies
Dr. Arnold Baskies Director

Dr. Baskies, Chairman of the Board of Directors of the American Cancer Society, is a fellowship trained surgical oncologist with special interests in breast cancer, thyroid cancer, and melanoma. He received his Bachelor of Arts degree summa cum laude and was a member of Phi Beta Kappa at Boston University, ...

Read More

David Cavalier
David Cavalier Director

Mr. Cavalier is a seasoned executive and investor with over 20 years of experience in the biotechnology sector. He is currently the President and Chief Operating Officer of Ambrosia Medical, LLC, a company providing therapy for age-related diseases. Previously, he was the Chairman and Chief Financial Officer of Aeolus Pharmaceuticals, ...

Read More

Sign up for email Updates

Be The First to Receive Breaking News

Sign Up Now
Logo Itus

Latest News & Events

Anixa Biosciences Releases Data Presented at AACR Artificial Intelligence Conference


Anixa Biosciences Files Pre-Submission and Requests Meeting with FDA Regarding Cchek™ Artificial Intelligence based Cancer Detection Technology


Anixa Biosciences Appoints Leading Researchers in Immuno-Oncology to its Scientific Advisory Board


Cancer Fact: 27% of global cancer deaths occur in China.